Understanding the Preparation
The foundation of PRP
Platelet-rich plasma is prepared from a sample of your own blood. Processing separates and concentrates the platelets, which contain growth factors and other proteins involved in the body’s response to injury. The resulting preparation is injected into a selected treatment area.
PRP preparations vary in their platelet concentration, cellular composition, and processing methods. These differences are relevant to treatment planning, although a higher concentration alone does not establish that a preparation will produce a better result.
What distinguishes SuperShot®
The SuperShot® process is designed to recover and reintroduce plasma components that may otherwise be excluded during conventional PRP preparation. These include extracellular vesicles, small particles released by cells that carry biological material involved in communication between cells.
The intention is to combine these additional plasma components with concentrated platelets, preserving more of the material present in the original blood sample. This describes the preparation’s approach rather than a guarantee of greater effectiveness.
The role of cellular signaling
Some extracellular vesicles carry microRNAs, molecules that help regulate gene activity and influence how cells respond to their environment. Researchers are investigating their roles in inflammation, tissue repair, and blood-vessel formation.
Exosomes are one type of extracellular vesicle and can be released by many kinds of cells, including stem cells. The presence of extracellular vesicles in a blood-derived preparation does not make it a stem-cell therapy or establish that it has the same effects as a stem-cell-derived product.
Its Place in Joint & Tendon Care
SuperShot® PRP may be considered for selected conditions affecting joints, tendons, and surrounding soft tissues. Suitability depends on the diagnosis, the extent of damage, previous treatment, and your goals for function.
At OWM, assessment considers both the symptomatic area and the structures that contribute to its stability and movement. Your provider may review imaging, examine how the joint moves, and discuss activities that provoke discomfort before recommending treatment.
For appropriate patients, a blood-derived injection may form part of a nonsurgical care plan. It does not guarantee restoration of damaged tissue or remove the need for surgery when surgery is clinically indicated.
The Treatment Experience
Assessment and planning
Your consultation includes a review of your symptoms, medical history, medications, and previous care. Your provider explains the rationale for the proposed treatment, its alternatives, and the evidence relevant to your condition.
Preparation and placement
A blood sample is collected and processed to create the injection preparation. Ultrasound guidance allows your provider to visualize the intended treatment area and guide the needle toward selected tissues.
Recovery and follow-up
Temporary soreness, swelling, or increased discomfort may occur after an injection. You will receive instructions on activity, medication use, and rehabilitation, with follow-up to assess your response.
Changes in pain and function, when achieved, develop gradually. The number and spacing of treatments are determined individually rather than through a fixed promise of recovery.
Expected Outcomes
The purpose of treatment is to address symptoms and support function within a considered recovery plan. The evidence for PRP varies by condition, and findings for conventional PRP cannot automatically be applied to every modified preparation.
Claims of exponentially greater potency, accelerated regeneration, or superior healing require direct clinical evidence. Your provider will discuss what is known about SuperShot® PRP, where uncertainty remains, and how that informs your treatment decision.
As with other injections, potential risks include bleeding, infection, and injury to nearby tissues. These considerations are reviewed alongside the potential benefits before you begin care.